Advanced Oncotherapy passes another key milestone

04:03 EDT 31 Jul 2017 | Proactive Investors

Advanced Oncotherapy PLC (LON:AVO) has reached another milestone in the development of its first LIGHT system, a next-generation proton therapy unit. For it has announced the final coupled cavity linac (CCL) module is ready for shipment to the Geneva testing facility. The CCL unit used to generate a beam capable of treating superficial tumours when integrated with all the other components. It means the LIGHT system remains on track to produce its first proton beam capable of treating cancer in the third-quarter of next year.  "The successful manufacture, performance testing and now delivery of the CCLs are a major milestone in the technological development of the LIGHT system,” said AVO chief executive Nicolas Serandour. “For the first time, we will now have all of the key high-speed accelerating modules for LIGHT in place in our Geneva site and with a great deal of the manufacturing risk behind us, we can focus on the integration and commissioning of the individual components. “This development brings the reality of the world's first linear proton accelerator in the treatment of cancer much closer."

Original Article: Advanced Oncotherapy passes another key milestone


More From BioPortfolio on "Advanced Oncotherapy passes another key milestone"

Quick Search

Relevant Topics

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...